Americas Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the Americas Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 4549 Mn in 2026 and is projected to reach USD 4902 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
• Of the 4 groups compared here, Anti-Infectives is out front by 2027 at 1. 60B USD — 33% of the group total.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 1596 Mn, with Others at USD 1248 Mn.

Market Dynamics

Of the 4 groups compared here, Anti-Infectives is out front by 2027 at 1.60B USD — 33% of the group total.

Second place: Others, 1.25B USD, trailing Anti-Infectives by 22%.

Anti-Infectives: up 76% over the period, 909.20M USD to 1.60B USD.

Others grows to 1.25B USD by 2027, from 675.48M USD in 2018 — 85% up.

Antibiotics: 680.89M USD in 2018 to 1.18B USD by 2027, up 73%.

Anti-Inflammatories climbs from 451.97M USD (2018) to 878.97M USD (2027), a 94% gain.

Anti-Inflammatories outpaces every other series here, 94% growth — worth watching even if it is not the biggest in absolute terms yet.

Add every series together and the total reaches 4.90B USD by 2027, 80% above the 2018 combined figure of 2.72B USD.

How The 4 Series Compare

There are 4 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.

Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.

Use this chart to size the Americas Companion Animal Healthcare market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.

The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.